Literature DB >> 14701801

Restricted expression and photic induction of a novel mouse regulatory factor X4 transcript in the suprachiasmatic nucleus.

Ryoko Araki1, Hirokazu Takahashi, Ryutaro Fukumura, Fuyan Sun, Nanae Umeda, Mitsugu Sujino, Shin-Ichi T Inouye, Toshiyuki Saito, Masumi Abe.   

Abstract

The regulatory factor X (RFX) family of transcription factors is characterized by a unique and highly conserved 76-amino acid residue DNA-binding domain. Mammals have five RFX genes, but the physiological functions of their products are unknown, with the exception of RFX5. Here a mouse RFX4 transcript was identified that encodes a peptide of 735 amino acids, including the DNA-binding domain. Its expression was localized in the suprachiasmatic nucleus, the central pacemaker site of the circadian clock. Also, light exposure was found to induce its gene expression in a subjective night-specific manner. Polyclonal antibodies were prepared, and an 80-kDa band was detected in the suprachiasmatic nucleus by Western hybridization. A histochemical study showed a localization of the products in the nucleus. This is the first report on mouse RFX4, which contains the RFX DNA-binding motif. Our investigation may provide clues to the physiological function of RFX4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14701801     DOI: 10.1074/jbc.M312761200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Regulatory factor X4 variant 3: a transcription factor involved in brain development and disease.

Authors:  Donghui Zhang; Darryl C Zeldin; Perry J Blackshear
Journal:  J Neurosci Res       Date:  2007-12       Impact factor: 4.164

2.  Autorepression of rfx1 gene expression: functional conservation from yeast to humans in response to DNA replication arrest.

Authors:  Yoav Lubelsky; Nina Reuven; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder.

Authors:  N Akula; J Barb; X Jiang; J R Wendland; K H Choi; S K Sen; L Hou; D T W Chen; G Laje; K Johnson; B K Lipska; J E Kleinman; H Corrada-Bravo; S Detera-Wadleigh; P J Munson; F J McMahon
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

4.  Differential expression of Rfx1-4 during mouse spermatogenesis.

Authors:  W Stephen Kistler; Gary C Horvath; Anindya Dasgupta; Malathi K Kistler
Journal:  Gene Expr Patterns       Date:  2009-07-19       Impact factor: 1.224

5.  G-protein pathway suppressor 2 (GPS2) interacts with the regulatory factor X4 variant 3 (RFX4_v3) and functions as a transcriptional co-activator.

Authors:  Donghui Zhang; G Jean Harry; Perry J Blackshear; Darryl C Zeldin
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

6.  T cell reactivity to regulatory factor X4 in type 1 narcolepsy.

Authors:  Guo Luo; Selina Yogeshwar; Ling Lin; Emmanuel Jean-Marie Mignot
Journal:  Sci Rep       Date:  2021-04-09       Impact factor: 4.379

7.  GOGOT: a method for the identification of differentially expressed fragments from cDNA-AFLP data.

Authors:  Koji Kadota; Ryoko Araki; Yuji Nakai; Masumi Abe
Journal:  Algorithms Mol Biol       Date:  2007-05-30       Impact factor: 1.405

8.  A normalization strategy applied to HiCEP (an AFLP-based expression profiling) analysis: toward the strict alignment of valid fragments across electrophoretic patterns.

Authors:  Koji Kadota; Ryutaro Fukumura; Joseph J Rodrigue; Ryoko Araki; Masumi Abe
Journal:  BMC Bioinformatics       Date:  2005-03-06       Impact factor: 3.169

9.  Identification of novel regulatory factor X (RFX) target genes by comparative genomics in Drosophila species.

Authors:  Anne Laurençon; Raphaëlle Dubruille; Evgeni Efimenko; Guillaume Grenier; Ryan Bissett; Elisabeth Cortier; Vivien Rolland; Peter Swoboda; Bénédicte Durand
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.